BBC Business
From glowing lollies to protein pints, ice cream makers are getting weird and wonderful - and using AI-powered fridges to keep your freezer stocked.
BBC Health
England's obesity rates have doubled since 1993, despite 14 government strategies - because apparently, convenience and cheap junk food are winning.
The Guardian Europe
Mini fridges are the latest bathroom flex, but dermatologists say most skincare doesn't need the chill - it's just a cool gimmick.
BBC World
Italy's children have swapped the Mediterranean diet for pizza, pasta, potatoes, protein, and bread - and the scales are not happy about it.
The Guardian Europe
Weight-loss jabs come with a laundry list of side effects - from Ozempic face to hair loss - but many are just the body's dramatic reaction to rapid weight loss, not the drugs themselves.
ZDNet
A 50-something tech journalist loses 100+ pounds with Mounjaro and a parade of gadgets to hike the Camino, proving that GLP-1 drugs and smart scales make for a surprisingly good travel partnership.
BBC Business
Weight-loss jabs are reshaping grocery baskets: less chocolate, more mouthwash - and a £780m hit to UK food spending.
BBC Health
About 1.6 million Brits are on weight-loss jabs, but a new study finds stopping them means gaining weight back four times faster than quitting the gym - because the universe has a sense of humour.
The Guardian
GLP-1 users save £418 a year on groceries, eat less chocolate, and want smaller restaurant portions - but the drugs are so expensive that 41% quit.
BBC Health
A new drug aims to prevent the dreaded 'Ozempic butt' by preserving muscle during weight loss, because apparently your glutes deserve better than a deflated balloon look.
ScienceDaily
GLP-1 weight-loss drugs like Ozempic may reduce breast cancer risk by 30%, researchers say - though they’re not ready to call it a miracle cure just yet.
ScienceDaily
NIH scientists discover why Ozempic and Wegovy weight loss eventually plateaus: some brain cells just stop paying attention to the drug.
ScienceDaily
Study finds Wegovy linked to rare 'eye stroke' causing sudden blindness - because weight loss drugs apparently want to keep you in the dark.
ScienceDaily
Aarhus University researchers found that GLP-1, the hormone behind Wegovy, is barely present in arthritic joints - but higher drug doses might fight inflammation directly, offering a potential bonus beyond weight loss.
BBC Health
Eli Lilly's orforglipron pill helps keep weight off after stopping obesity jabs, but experts warn it may be a lifelong commitment.
The Atlantic
Soylent failed because it was too honest about replacing food. Now protein shakes sell the same thing with better branding, adaptogens, and a promise you'll get jacked.
ScienceDaily
Scientists trick cells into accepting a metabolic package deal, and mice are eating less and losing weight - but humans should hold their hors d'oeuvres.
The Good Times
One sardonic roundup, delivered on your schedule. Free. Unsubscribe whenever your tolerance for wit runs out.
Already subscribed but we never reach your inbox? Check your spam folder and hit 'Not spam' (or 'Remove from spam') to bust us out of junk-mail purgatory. You'll be helping everyone else too.
The Good Times
One sardonic roundup, delivered on your schedule. Free. Unsubscribe whenever your tolerance for wit runs out.
Already subscribed but we never reach your inbox? Check your spam folder and hit 'Not spam' (or 'Remove from spam') to bust us out of junk-mail purgatory. You'll be helping everyone else too.
Don't open any of our emails for a month and you'll be automatically removed from the mailing list.